Global Education Ltd Share Price Today

Actions	Ex-Date	Record-Date
DividendsFinal Dividend of 25% at ₹0.5/Share	17-Jul-2026	17-Jul-2026
DividendsInterim Dividend of 25% at ₹0.5/Share	12-Nov-2025	12-Nov-2025
DividendsFinal Dividend of 25% at ₹0.5/Share	11-Jul-2025	11-Jul-2025
Stock Split2:5	10-Dec-2024	10-Dec-2024

StockYard ( SEBI RA )

3 Sep • 1:21 AM · SEBI-Registered Analyst

🚨 Centum Electro Gets ₹30.5 Cr Order for Electro Systems

📡 ₹30.5 Cr Order for Electronic Systems Centum Electronics has secured an export order worth $3.22 million (approximately ₹30.5 crore) from a global OEM customer for the design, development and delivery of electronic systems. The project is scheduled to be executed over the next seven months. The order strengthens Centum’s exposure to high-value electronics and global OEM programs, an area where India is seeing increasing demand as companies diversify their electronics supply chains and expand outsourced engineering and manufacturing. For Centum, the contract is also relevant because the scope includes design and development, rather than only manufacturing, potentially supporting its higher-value engineering capabilities. Execution and future order wins will remain important for assessing the broader impact. 📌 StockYard Insight: The ₹30.5 crore export order provides near-term revenue visibility and reinforces Centum’s global OEM business. Investors should track execution, margins and repeat orders to gauge the sustainability of this growth. #CentumElectronics #ElectronicsManufacturing #ExportOrder #DefenceElectronics #Engineering #StockYardResearch

Saurabh Tyagi--Clovek,Advisory

2 Sep • 11:21 PM · SEBI-Registered Analyst

Sun Pharma entered into an agreement with U.S. government

SUNPHARMA

has entered into an agreement with the U.S. government under which it will extend Most Favoured Nation (MFN) pricing to state Medicaid programmes and apply the framework to future innovative medicine launches. In return, the company has secured a delay of more than two years in the application of Section 232 tariffs on its innovative pharmaceutical products. The agreement provides greater visibility for Sun Pharma’s U.S. innovative-medicines business, which is an important growth driver for the company. The U.S. contributes around 27% of Sun Pharma’s global revenue, while its innovative medicines portfolio accounts for about 22% of sales. The key positive is reduced tariff uncertainty. A more than two-year reprieve gives Sun Pharma additional time to scale its U.S. specialty business without an immediate tariff burden. This is particularly relevant as the company continues to strengthen its presence in higher-value therapies. However, MFN pricing also means lower prices for medicines supplied to Medicaid and potentially lower price realisation on future innovative launches. The exact commercial terms remain confidential, making it difficult to quantify the near-term earnings impact.

Harsh Vardhan

2 Sep • 10:41 PM · SEBI-Registered Analyst

Sun Pharma: Global Specialty Pharma Growth Engine

SUNPHARMA

Sun Pharmaceutical Industries remains India’s largest pharma company, with strong exposure to specialty medicines, generics, India formulations and emerging markets. Q1 FY27 results are available on the company’s investor portal, with continued focus on specialty products and global expansion. Latest News: Sun Pharma received approval to manufacture and market semaglutide in Brazil and launched generic semaglutide in South Africa. The company is also progressing on Nidlegy, while shareholders of Organon approved the proposed acquisition, an important strategic development for Sun Pharma. Corporate Action/Catalysts: The Organon transaction, specialty-drug pipeline, semaglutide opportunity and continued US growth provide significant long-term catalysts. The company also completed its 34th AGM on 31 July 2026 and recommended FY26 final dividend. Key risks include US pricing pressure, regulatory scrutiny, acquisition execution and high expectations embedded in valuation.

Prameela Balakkala

2 Sep • 10:20 PM · SEBI-Registered Analyst

Syrma SGS Opens Bengaluru Facility with Elemster JV

SYRMA

Syrma SGS Technology Ltd (SYRMA) Expansion Update: Company inaugurates a state‑of‑the‑art high‑reliability electronics manufacturing facility in Bengaluru, established under a joint venture with Elemster S.p.A. The facility will support domestic and global markets in critical sectors, enhancing Syrma’s manufacturing footprint. 📊 Key Highlights Facility Location: Bengaluru, Karnataka JV Partner: Elemster S.p.A Focus: High‑reliability electronics manufacturing Markets Served: Domestic and global critical sectors Impact: Strengthens production capacity and competitiveness 🏭 Fundamentals Snapshot (FY26) Revenue: ~₹3,600 crore EBITDA Margin: ~14% PAT: ~₹310 crore Debt-to-Equity: ~0.4 Capex Plan: Facility expansion in Bengaluru and R&D investments 📊 Key Ratios (FY26) Metric Value ROE ~13% ROCE ~14% Debt-to-Equity ~0.4 P/E Ratio ~22x This post is for informational purposes only and should not be construed as investment advice. Investors are advised to conduct their own research or consult financial advisors before making investment decisions.

DEEPAK PAL

2 Sep • 9:44 PM · SEBI-Registered Analyst

Crude ki तपिश aur Iran tension 24k ke नीचे Nifty me सावधानी?

Crude Oil: Brent crude is hovering around $95, making it the biggest risk factor for Indian markets. Continued volatility in crude could put pressure on OMCs, Aviation, Paints and Chemical stocks. US–Iran Tensions: Concerns over potential oil supply disruptions remain elevated, keeping global risk sentiment cautious and volatility high. US Bond Yields: The US 10-Year yield remains elevated. Rising rate expectations could weigh on FII flows and emerging-market sentiment. Rupee: The RBI’s intervention to support the rupee, along with movements in crude and the dollar, will remain closely watched. Nifty: Nifty closed below the crucial 24,000 mark. 24,000 is now an immediate resistance, while 23,850–23,800 remains the key support zone. Stock-Specific Action:

RELIANCE

Reliance Industries, Wipro and Tata Motors are likely to remain in focus amid stock-specific news and developments.

Kulneet singh

2 Sep • 9:16 PM · SEBI-Registered Analyst

MSCI Exit Adds Fresh Technical Pressure on Swiggy

SWIGGY

is facing a different kind of pressure right now, and this has more to do with index eligibility and foreign ownership limits than any immediate change in its underlying business. MSCI has decided to remove Swiggy from its Global Standard Indexes effective September 7, 2026, under the foreign ownership limit event category. This comes after Swiggy moved towards becoming an Indian-owned and controlled company, with shareholders approving proposals to cap foreign shareholding at 49.5%. The company also entered NSDL’s red flag list on September 1 after foreign ownership moved within three percentage points of the applicable FPI limit. According to the reported data, foreign investors can now purchase a maximum of around 2.8 crore additional Swiggy shares. For me, the important learning here is how index-related events can influence a stock even when they are not directly connected to operating performance. Funds that track MSCI indices may need to adjust their holdings after the deletion, potentially creating additional selling pressure around the effective date. Swiggy shares have already been under pressure, falling 4% to ₹264.55 and extending their two-day decline to around 6%. I would therefore separate this event from the company’s business fundamentals. Index exclusion can create short-term technical pressure, while Swiggy’s longer-term performance will still depend on growth, profitability and execution across food delivery and quick commerce. Learning Outcome: Index inclusion or exclusion can create temporary buying or selling flows because passive funds need to rebalance their portfolios. Such technical flows should be analysed separately from changes in a company’s underlying business.

Global Education Ltd Share Price

Overview

Market Data

Open Price

Prev. Close

Day Low

Day High

52 Week Low

52 Week High

Fundamentals

Quick Bite

Price To Earnings Ratio

Sector PE

PB Ratio

Sector PB

EPS

Dividend Yield

Today's Volume

5 Day Avg. Volume

PEG Ratio

Market Cap.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Mutual Fund Ownership

About Global Education Ltd 👋

Expert Opinions

News & Events

Frequently Asked Questions

What is the share price of Global Education Ltd?

What is the market cap of Global Education Ltd?

Should I buy Global Education Ltd stock now?

What is the 52 week high and low of Global Education Ltd?

Is the Global Education Ltd stock good to buy?

Is Global Education Ltd a good buy for the long term?

Is Global Education Ltd overvalued or undervalued?

What is the PE and PB ratio of Global Education Ltd?